Low-Dose Oral Minoxidil: Hair Growth May Peak After 6 Months

Published Date: 18 Apr 2026

Low dose oral minoxidil yields measurable increases in frontal hair density by 3-6 months, with no further significant gains up to 36 months, a retrospective review finds.

Read Full News

Latest News

CAR T-Cell Therapy for Skin Diseases Near Approval

CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

Eczema and the Topical Steroid Withdrawal Controversy

Topical steroid withdrawal is a controversial topic. What matters is treating patients with compassion and supporting them in their decision to stop treatment.

MCC Linked to Higher Mortality, Healthcare Use

Patients with Merkel cell carcinoma had higher mortality, more hospitalizations, and a greater comorbidity burden than matched patients without the disease and several other cancer cohorts in a study.

Judge Blocks Colorado's First-of-its-kind Price Cap on Amgen's Enbrel

A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of-its-kind move ⁠by a U.S. state.

Androgenetic Alopecia Often Missed in Teens

Androgenetic alopecia is the most common form of hair loss in adolescents but often goes unrecognized even as new treatments are emerging for other forms of alopecia.

Influencers & UV Misinformation: What Can Dermatologists Do?

Misinformation about sun exposure and alternative tanning methods abounds on social media. What can dermatologists do to keep people safe?

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Latest News

CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

Topical steroid withdrawal is a controversial topic. What matters is treating patients with compassion and supporting them in their decision to stop treatment.

Patients with Merkel cell carcinoma had higher mortality, more hospitalizations, and a greater comorbidity burden than matched patients without the disease and several other cancer cohorts in a study.

A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of-its-kind move ⁠by a U.S. state.

Androgenetic alopecia is the most common form of hair loss in adolescents but often goes unrecognized even as new treatments are emerging for other forms of alopecia.

Misinformation about sun exposure and alternative tanning methods abounds on social media. What can dermatologists do to keep people safe?

News All Time

US FDA Reverses Course on Regenxbio's Rare-disease Gene Therapy, Backs Accelerated Approval Bid

Regenxbio said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support ⁠an accelerated approval application, reversing course...

Geographic and Income Data Missing From Cancer Trial Reports

Researchers conducted a systematic review of 441 US-based randomized cancer treatment trials to see what patient characteristics were reported.

Can Printed ‘Skin’ Help to Heal Burns Without Scars?

Inks created with a patient’s own cells may one day help the body regrow tissues.

Down Syndrome: Skin Conditions That Demand Attention

Psoriasis, hidradenitis suppurativa, alopecia areata, and other skin conditions are more common in people with Down syndrome and require multidisciplinary, mechanism-specific management, experts say.

Nicotinamide Cost-Effective for Reducing KC Risk

The study in US veterans found that oral nicotinamide was 'a cost-effective and patient-centric preventive approach' for keratinocyte carcinoma (KC), the study authors reported.

FDA Approves Hyaluronic Acid Filler for Reducing Neck Lines

A hyaluronic acid injectable product previously approved for cheek smoothing gets a new indication for reducing horizontal neck wrinkles.

Barcelona Cases Point to an Emerging Transmissible Dermatosis

Ten confirmed cases in Barcelona suggest that a rare skin infection may be spreading through sexual networks, prompting earlier recognition and coordinated surveillance.

Is Hidradenitis Suppurativa More Than a Skin Disease?

New evidence highlights genetic, metabolic, and immune drivers of hidradenitis suppurativa, supporting more coordinated care across specialties.

Surgical Plume Prevalent but Safety Protocols May Be Lacking

Surgical plume exposure occurs frequently for clinicians who perform laser-based procedures, but a new study suggests there is a lack of awareness of specific hazards.

How Blood Transfusion Became Safer

A practice once driven by hopes of restoring life and vitality is now a high-precision therapy where every unit of blood must be matched, tested, and traced.

Are Drug‑Resistant Infections Outpacing Industry Efforts?

High-quality research and proper antimicrobial stewardship can hold the key to mitigating antibiotic resistance.

Vulvar Melanoma Outcomes Worse With Surgery Delay

Surgical delays of 91 days and longer from diagnostic biopsy are linked to positive margins and worse survival in patients with early-stage vulvar melanoma, study finds.

Elicio Shares Slide After Pancreatic Cancer Vaccine Falls Short in Mid-stage Study

Elicio Therapeutics shares fell about 72% on Monday after the biotech firm's experimental pancreatic cancer vaccine ⁠failed to significantly extend the time patients lived...

Social Media Sunscreen Recipes Raise Safety Concerns

Homemade sunscreen recipes are gaining attention, but laboratory studies suggest they may reduce ultraviolet damage unevenly and fail against key sunburn markers.

Cutaneous Lupus Flares Peak During Late Perimenopause

Cutaneous lupus flares increase during late perimenopause and remain elevated after menopause, study finds.

UKHSA: New Pandemic More Than 25% Likely Within 5 Years

Influenza and novel coronavirus top a new UKHSA threat register covering 22 risks, from dengue to drug-resistant infections.

Recommended News For You

Advances in "next generation" photoactive cancer therapy

Do I qualify for a cancer clinical trial?

GuCS: Genitourinary Cancers Symposium

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

The importance of breast cancer screening

Parents, teachers at Missouri school want answers after string of cancer diagnoses

Recommended Articles For You

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment 

Innovative Practices in Hematology in the Digital Era 

The Latest Research on Wiskott Aldrich Syndrome  

Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Radioactive ion beams successfully treat animal tumors in study

2.

A computer-aided diagnostic system for improved detection of breast cancer.

3.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

4.

Study reveals that older women frequently receive an incorrect breast cancer diagnosis.

5.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

1.

The Impact of Microadenoma on Hormonal Health

2.

Unlocking the Mysteries of the Axillary Vein: Exploring its Role in Human Anatomy

3.

ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection

4.

The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition

5.

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

2.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

3.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot